AI assistant
REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2021
Sep 17, 2021
29977_dirs_2021-09-17_ffb53b0d-5c84-4c56-9fa8-c7ddd3a2caff.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REGENERON PHARMACEUTICALS, INC. (REGN)
CIK: 0000872589
Period of Report: 2021-09-15
Reporting Person: COLES N ANTHONY (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-15 | Common Stock | M | 6909 | $380.95 | Acquired | 7811 | Direct |
| 2021-09-15 | Common Stock | M | 5039 | $345.47 | Acquired | 12850 | Direct |
| 2021-09-15 | Common Stock | S | 300 | $651.36 | Disposed | 12550 | Direct |
| 2021-09-15 | Common Stock | S | 1101 | $652.95 | Disposed | 11449 | Direct |
| 2021-09-15 | Common Stock | S | 800 | $653.31 | Disposed | 10649 | Direct |
| 2021-09-15 | Common Stock | S | 403 | $655.14 | Disposed | 10246 | Direct |
| 2021-09-15 | Common Stock | S | 1400 | $656.48 | Disposed | 8846 | Direct |
| 2021-09-15 | Common Stock | S | 835 | $657.53 | Disposed | 8011 | Direct |
| 2021-09-15 | Common Stock | S | 935 | $658.65 | Disposed | 7076 | Direct |
| 2021-09-15 | Common Stock | S | 300 | $659.0 | Disposed | 6776 | Direct |
| 2021-09-15 | Common Stock | S | 448 | $660.78 | Disposed | 6328 | Direct |
| 2021-09-15 | Common Stock | S | 3344 | $661.56 | Disposed | 2984 | Direct |
| 2021-09-15 | Common Stock | S | 3 | $662.55 | Disposed | 2981 | Direct |
| 2021-09-15 | Common Stock | S | 905 | $663.73 | Disposed | 2076 | Direct |
| 2021-09-15 | Common Stock | S | 1174 | $664.32 | Disposed | 902 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-09-15 | Non-Qualified Stock Option (right to buy) | $345.47 | M | 5039 | Disposed | 2027-01-27 | Common Stock (5039) | Direct |
| 2021-09-15 | Non-Qualified Stock Option (right to buy) | $380.95 | M | 6909 | Disposed | 2028-01-02 | Common Stock (6909) | Direct |
Footnotes
F1: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2: Represents volume-weighted average price of sales of 1,101 shares of Company stock on September 15, 2021 at prices ranging from $652.48 to $652.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
F3: Represents volume-weighted average price of sales of 800 shares of Company stock on September 15, 2021 at prices ranging from $653.11 to $653.52. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
F4: Represents volume-weighted average price of sales of 403 shares of Company stock on September 15, 2021 at prices ranging from $655.14 to $655.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
F5: Represents volume-weighted average price of sales of 1,400 shares of Company stock on September 15, 2021 at prices ranging from $656.18 to $656.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
F6: Represents volume-weighted average price of sales of 448 shares of Company stock on September 15, 2021 at prices ranging from $660.29 to $660.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
F7: Represents volume-weighted average price of sales of 3,344 shares of Company stock on September 15, 2021 at prices ranging from $661.02 to $661.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
F8: Represents volume-weighted average price of sales of 905 shares of Company stock on September 15, 2021 at prices ranging from $663.15 to $663.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
F9: Represents volume-weighted average price of sales of 1,174 shares of Company stock on September 15, 2021 at prices ranging from $664.00 to $664.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
F10: The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.